Skip to main content

Qatar Investment Authority — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

53
Companies
$12.2B
Total invested
$233.9M
Avg. check
46
Industries
Biotechnology 12Health Care 10Medical 10Therapeutics 6Biopharma 3Life Science 3+40 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 53
Praxis Precision Medicines
January 2026

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Alternative Medicine · Cambridge$575.0M Post Ipo Equity
Akura Medical
December 2025

Akura Medical is developing a next-generation thrombectomy device that aims to simplify thrombectomy through an easy-to-use.

Health Care · Los Gatos$53.0M Series C
Tessera Therapeutics
December 2025

Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ to drive advancements in genome engineering.

Biopharma · Cambridge$150.0M Corporate Round
Mujin
December 2025

Mujin provides automation solutions for industrial robots to simplify factory and logistics automation and increase worldwide productivity.

Artificial Intelligence (AI) · Tokyo$134.4M Series D
d-Matrix
November 2025

D-Matrix is a platform that enables data centers to handle large-scale generative AI inference with high throughput and low latency.

AI Infrastructure · Santa Clara$275.0M Series C
Kailera Therapeutics
October 2025

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

Biotechnology · Waltham$600.0M Series B
Pepgen
September 2025

PepGen is empowering nucleic acid therapeutics to go the distance.

Biotechnology · Oxford$115.0M Post Ipo Equity
SK on
July 2025

SK on develops and manufactures high-energy density electric vehicle batteries.

Automotive · Seoul$1.4B Debt Financing
ARTBIO
July 2025

ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.

Biotechnology · Cambridge$132.0M Series B
Ascend Elements
June 2025

Ascend Elements manufactures sustainable battery materials using elements from discarded lithium-ion batteries.

Advanced Materials · WestboroughSeries D
GlycoEra
May 2025

GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.

Biotechnology · Schlieren$130.0M Series B
Lomond Therapeutics
March 2025

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

Biopharma · San Diego$20.0M Series Unknown
Supira Medical
March 2025

Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions.

Health Care · Los Gatos$120.0M Series E
Latigo Biotherapeutics
March 2025

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.

Biotechnology · Thousand Oaks$150.0M Series B
Voldex
February 2025

Voldex is the premier home for top games on Roblox

Content Creators · LondonDebt Financing
Fluence
December 2024

Fluence makes energy storage technology solutions and services.

Energy · Arlington$400.0M Post Ipo Debt
ONE Championship
October 2024

ONE Championship is a global combat sports promotion featuring MMA, Muay Thai, and kickboxing.

Broadcasting · Singapore$50.0M Series Unknown
Outpace Bio
August 2024

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Biotechnology · Seattle$144.0M Series B
Bright Peak Therapeutics
June 2024

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Biotechnology · Allschwil$90.0M Series C
Clove Dental
November 2023

Clove Dental is a dental chain that provides end to end oral healthcare services.

Dental · New Delhi$50.1M Series E
OncoResponse
May 2023

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

Biopharma · Seattle$14.0M Series D
The North Road Company
January 2023

The North Road Company is a multi-genre studio that produces scripted, documentary, and non-scripted film and TV content.

Film Production · Los Angeles$150.0M Private Equity
Codiak Biosciences
September 2022

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

Biotechnology · San Francisco$20.0M Post Ipo Equity
Starling Bank
April 2022

Starling Bank is a bank that offers personal, joint, and business accounts.

Banking · London$164.2M Series D

Where Qatar Investment Authority invests

Biotechnology12
Health Care10
Medical10
Therapeutics6
Biopharma3
Life Science3

About Qatar Investment Authority's portfolio

How many companies has Qatar Investment Authority invested in?

Qatar Investment Authority has invested in 53 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Qatar Investment Authority invest in?

Qatar Investment Authority's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Biopharma. The firm invests across 46 different industry categories.

What is Qatar Investment Authority's largest investment?

Among tracked funding rounds, SK on received $1.4B in a Debt Financing round. Qatar Investment Authority's total known invested capital is $12.2B.

What is the average investment size for Qatar Investment Authority?

Qatar Investment Authority's average investment size is $233.9M across its portfolio of 53 companies.

What are Qatar Investment Authority's most recent investments?

Recent Qatar Investment Authority portfolio additions include Praxis Precision Medicines, Akura Medical, Tessera Therapeutics, Mujin, d-Matrix. These companies were founded in 2020 or later.

Reach the founders behind these 53 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →